October 30, 2017 / 1:22 PM / 23 days ago

BRIEF-Bayer says FDA accepts BLA filing for treatment of Hemophilia A

Oct 30 (Reuters) - Bayer AG

* Bayer - ‍U.S. FDA accepted co’s BLA filing for bay94-9027 for treatment of Hemophilia A in adults and adolescents 12 years of age and over​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below